Castle Biosciences CSTL Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| NET REVENUES by Product | ||||||
| Dermatologic | $41.11M-34.7% | $48.59M-23.8% | $48.52M-25.4% | $56.3M-18.2% | $62.96M+6.1% | |
| Non-Dermatologic | $42.57M+70.1% | $38.42M+70.5% | $34.52M+66.6% | $29.89M+64.5% | $25.03M+83.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Castle Biosciences break its business down?
- Castle Biosciences (CSTL) reports net revenues by product across 2 parts — Dermatologic and Non-Dermatologic. Each is extracted from the segment footnotes and tracked over time.
- Where does Castle Biosciences's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Castle Biosciences's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
